Thanks to high price gains in the heavily weighted Siemens shares, the regained strength of the DAX continued to rise on Thursday. US economic data published in the afternoon provided additional support because they fueled hopes that interest rates would reach their peak. However, the increase of 0.24 percent to 15,786.61 points was limited compared to the last few days.
Thanks to high price gains in the heavily weighted Siemens shares, the regained strength of the DAX continued to rise on Thursday. US economic data published in the afternoon provided additional support because they fueled hopes that interest rates would reach their peak. However, the increase of 0.24 percent to 15,786.61 points was limited compared to the last few days.
The MDax of medium-sized companies lost 1.84 percent to 25,968.50 points due to a historic drop in Hellofresh’s share price. In Europe, major indices paid tribute to their recent recovery. The EuroStoxx 50 ended trading 0.3 percent lower. In Paris and especially in London things went downhill even more significantly. The US leading index Dow Jones Industrial, however, rose by almost 0.5 percent at the close of the European stock market.
Siemens shares gained 5.7 percent after what traders said was a surprisingly positive outlook.
In contrast, Hellofresh suffered the highest price loss in the company’s history at minus 22.4 percent. The surprising reduction in outlook just a few weeks after the presentation of quarterly figures cost the meal kit retailer a lot of credibility in the market.
The ticket marketer CTS Eventim confirmed its forecast after nine-month figures. The company had significantly increased sales and operating profit thanks to several major events and stronger demand for tickets. The shares, however, lost 3.2 percent. JPMorgan said that the fact that the forecast had not been increased again could temper the enthusiasm somewhat.
The shares of the chemical company BASF and the fertilizer company K+S fell by 2.5 and 5.2 percent respectively. They suffered from negative analyst assessments.
The papers of the active ingredient researcher Morphosys fell by more than eleven percent as the bottom of the small cap index SDax. This continued the downward trend that began a week ago – the joy over the announced earlier publication of important study results was only short-lived. In addition to the company, analysts also have high expectations for the active ingredient pelabresib for the treatment of myeolofibrosis, a rare form of blood cancer. The share price, which has had a strong run since the beginning of the year, is correspondingly high if the data disappoints.
The euro only temporarily benefited from the US data and recently showed little movement at 1.0854 US dollars. The European Central Bank (ECB) set the reference rate at $1.0849.
On the German bond market, the current yield rose from 2.61 percent the day before to 2.64 percent. The Rex bond index fell by 0.13 percent to 124.10 points. The Bund future gained 0.43 percent to 131.03 points.
Source: Stern
